Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy - Drug Trials For Money - Paid Clinical Trials

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
Conditions:   NSCLC;   Non-small Cell Lung Cancer;   Lung Cancer;   Non-small Cell Lung Cancer Stage I;   Non-small Cell Lung Cancer Stage II;   Non-small Cell Lung Cancer Stage III;   Non-small Cell Lung Cancer Stage IIIA;   PD-L1 Gene Mutation
Interventions:   Drug: Durvalumab;   Radiation: Stereotactic Body Radiation Therapy
Sponsors:   Memorial Sloan Kettering Cancer Center;   AstraZeneca
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 29, 2021 / by / in
Comments